Health care companies are also subject to competitive forces that may result in price discounting, may be thinly capitalized and susceptible to product obsolescence
SN : Why dont we have a definitive answer yet
Not everyone will lose exactly 41 pounds, and not everyone will build muscle during significant fat loss, even with TRT and medication support
Annualized cost comparisons in 2026: Bariatric surgery (gastric sleeve or bypass): ,000 to ,000 one-time, often covered by insurance for severe obesity Wegovy at list price: about ,200 per year Zepbound at list price: about ,720 per year Compounded semaglutide (legitimate US pharmacy): ,800 to ,000 per year Compounded tirzepatide: ,000 to ,000 per year Retatrutide at launch will likely fit in the Wegovy/Zepbound range at list price, with significantly lower out-of-pocket cost for insured patients with savings card eligibility